BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 30, 2010
 |  BC Week In Review  |  Company News  |  Deals

MannKind, Juvenile Diabetes Research Foundation deal

MannKind will supply its Afrezza inhaled diabetes treatment to the foundation to use in the pilot trial of an artificial pancreas developed by University of California Santa Barbara...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >